Also listed on Interleukin Genetics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends no later than Apr 19, 2032 · Medium confidence
20-year base term ends Dec 9, 2031
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Dec 9, 2011
Apr 19, 2032
May 24, 2016
This patent's term runs 132 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 9, 2011, when application 13/316,198, the earliest non-provisional in its chain, was filed (this one was filed Aug 8, 2013) | Dec 9, 2031 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +132 days, USPTO patent term adjustment record | Apr 19, 2032 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Apr 19, 2032 | Medium confidence |
This family
| Application 13/316,198 | Abandoned not computed | not computed |
| US 9,347,090 | this patent no later than Apr 2032 | no later than Apr 2032 |
| Application 15/144,263 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 18, 2013 Reel 31231, frame 568 | Kornman, Kenneth; Wu, Xiaodong; Wang, Hwa-ying; Rogus, John | Interleukin Genetics, Inc. | Assignment of Assignor's Interest |
| Apr 13, 2017 Reel 42001, frame 331 | Interleukin Genetics, Inc. | Horizon Technology Finance Corporation | Security Interest |
| Nov 27, 2017 Reel 44511, frame 428 | Horizon Technology Finance Corporation | Interleukin Genetics Inc. | Release of Security Interest |
| Nov 27, 2017 Reel 44511, frame 467 | Horizon Technology Finance Corporation | Interleukin Genetics, Inc. | Release of Security Interest |
| Dec 8, 2017 Reel 44341, frame 18 | Interleukin Genetics, Inc. | ORIG3N, Inc. | Assignment of Assignor's Interest |
| May 26, 2022 Reel 60028, frame 276 | Seaport Diagnostics, Inc. | Sapphiros Laboratories LLC | Assignment of Assignor's Interest |
| May 26, 2022 Reel 60389, frame 510 | ORIG3N, Inc. | Seaport Diagnostics, Inc. | Change of Name |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Apr 19, 2032. We will not guess the cap.